Haematology
- MANUFACTURER: Alexion Pharmaceuticals
- USAGE: Intravenous
- MEDICINE APPROVED BY:
- European Medical Agency (EMA)
- Food and Drug Administration (FDA)
- Pharmaceuticals and Medical Devices Agency (PMDA)
Ultomiris, with the generic name ravulizumab, is a prescription medication used in the treatment of two rare and serious blood disorders: paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).
Read more